Real-time enrollment status for this multi-drug resistant organism colonization clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:34 PM UTC
| NCT Number | NCT06321536 |
| Recruiting Status | Recruiting |
| Condition | Multi-Drug Resistant Organism Colonization |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | November 5, 2025 (Nov 5, 2025) |
As of July 18, 2026: Clinical trial NCT06321536 is currently recruiting participants. This phase2 study for multi-drug resistant organism colonization is actively seeking new participants at 4 locations across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06321536 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06321536 was last updated Nov 5, 2025 (November 5, 2025). HelloStudys verifies this status automatically.